While HPV-HNSCC frequently features mut-P53, elevated pRB, and low P16 expression, HPV+ cancers exhibit low P53 and pRB1 levels due to proteasomal degradation and elevated P16 [43]. This evidence concerns the gene CDKN2A and cancer.